Cargando…
The glial response to intracerebrally delivered therapies for neurodegenerative disorders: is this a critical issue?
The role of glial cells in the pathogenesis of many neurodegenerative conditions of the central nervous system (CNS) is now well established (as is discussed in other reviews in this special issue of Frontiers in Neuropharmacology). What is less clear is whether there are changes in these same cells...
Autores principales: | Cicchetti, Francesca, Barker, Roger A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4090753/ https://www.ncbi.nlm.nih.gov/pubmed/25071571 http://dx.doi.org/10.3389/fphar.2014.00139 |
Ejemplares similares
-
Current Understanding of the Glial Response to Disorders of the Aging CNS
por: Barker, Roger A, et al.
Publicado: (2012) -
Neurodegenerative disorders: the Glia way forward
por: Barker, Roger A., et al.
Publicado: (2014) -
Tau: A Common Denominator and Therapeutic Target for Neurodegenerative Disorders
por: Maxan, Alexander, et al.
Publicado: (2018) -
Therapeutic drug repositioning with special emphasis on neurodegenerative diseases: Threats and issues
por: Kakoti, Bibhuti Bhusan, et al.
Publicado: (2022) -
Imaging of Microglia in Patients with Neurodegenerative Disorders
por: Politis, Marios, et al.
Publicado: (2012)